Evidence map›Paper›PMID 31518521›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Dynamics of the human skin mediator lipidome in response to dietary ω-3 fatty acid supplementation.

Alexandra C Kendall, Suzanne M Pilkington, Sharon A Murphy, Francesco Del Carratore, Anggit L Sunarwidhi, Magdalena Kiezel-Tsugunova, Paula Urquhart, Rachel E B Watson, Rainer Breitling, Lesley E Rhodes and 1 more

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. An adaptableMolecular omics · 2024
    Article
  8. Restorative Effect of MicroalgaeInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Untargeted serum metabolomic profiling for early detection ofFrontiers in cellular and infection microbiology · 2022
    Article
  14. Article
  15. Host/Metabolites · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  20. Mediterranean Diet: Lipids, Inflammation, and Malaria Infection.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Alexandra C KendallDivision of Pharmacy and Optometry, Laboratory for Lipidomics and Lipid Biology, School of Heath Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Suzanne M Pilkington *Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, United Kingdom.
Sharon A Murphy *Division of Pharmacy and Optometry, Laboratory for Lipidomics and Lipid Biology, School of Heath Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Francesco Del CarratoreSchool of Chemistry, Faculty of Science and Engineering, The University of Manchester, Manchester, United Kingdom.
Anggit L SunarwidhiDivision of Pharmacy and Optometry, Laboratory for Lipidomics and Lipid Biology, School of Heath Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Magdalena Kiezel-TsugunovaDivision of Pharmacy and Optometry, Laboratory for Lipidomics and Lipid Biology, School of Heath Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Paula UrquhartDivision of Pharmacy and Optometry, Laboratory for Lipidomics and Lipid Biology, School of Heath Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Rachel E B WatsonDivision of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, United Kingdom.
Rainer BreitlingSchool of Chemistry, Faculty of Science and Engineering, The University of Manchester, Manchester, United Kingdom.
Lesley E RhodesDivision of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, United Kingdom.
Anna NicolaouDivision of Pharmacy and Optometry, Laboratory for Lipidomics and Lipid Biology, School of Heath Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Lipidomix (Germany) · DEDepartment of Physics, Mathematics and Informatics · BYManchester University NHS Foundation Trust · GBSalford Royal NHS Foundation Trust · GBUniversity of Manchester · GB

Funding

Biotechnology and Biological Sciences Research CouncilWellcome TrustWellcome Trust WT094028/AIAWellcome Trust WT094028/B
6 · The paper itself

Abstract

Nutritional supplementation with fish oil or ω-3 (n-3) polyunsaturated fatty acids (PUFAs) has potential benefits for skin inflammation. Although the differential metabolism of the main n-3PUFA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) could lead to distinct activities, there are no clinical studies comparing their relative efficacy in human skin. Following a 10-wk oral supplementation of healthy volunteers and using mass spectrometry-based lipidomics, we found that n-3PUFA mainly affected the epidermal mediator lipidome. EPA was more efficient than DHA in reducing production of arachidonic acid-derived lipids, and both n-3PUFA lowered

Indexed as

Dietary SupplementsLipidomicsAdolescentAdultCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFatty Acids, Omega-3FemaleHumansMaleMiddle AgedSkinYoung AdultFatty Acids, Omega-3docosahexaenoic acideicosapentaenoic acidinflammationlipidomicsmass spectrometry

Identifiers

PMID31518521
PMCPMC6902719
OpenAlexW2972608400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.